SUBSCRIBE
SUBSCRIBE
News   Business

CytRx Corporation Reports 2010 Second Quarter Financial Results

August 9, 2010 | 
1 min read
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today reported financial results for the three months and six months ended June 30, 2010 and provided a business update.
Earnings
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Pharming’s Restructuring Triggers 20% Workforce Reduction
October 6, 2025
 · 
216 min read
 · 
BioSpace Editorial Staff
Facade of AstraZeneca's office in Shanghai, China
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
October 6, 2025
 · 
1 min read
 · 
Tristan Manalac
Group of blue paper boats following on red on yellow background, mass manipulation
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
 · 
3 min read
 · 
Annalee Armstrong